Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
The agency regulating all things related to psychedelic-assisted therapy (PAT), Health Canada released a notice to stakeholders on risk-management measures for clinical trials, a seemingly supporting move towards future government-supported access.
As stated, the purpose of notice 22-111811-471 is to outline Health Canada's expectations regarding the implementation of risk-management measures by clinical trial sponsors and reflect on the "best practices emerging in the literature" of PAT in a context where there are no established clinical practice guidelines set yet.
Separately, two Quebec...
Login or create a forever free account to read this news
Sign up/Log in